Every material Form 8-K Sylvamo filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Sylvamo reported a third-quarter 2026 net loss of $199 million, or $4.98 per diluted share, driven by a $284 million loss from discontinued operations, primarily a noncash impairment tied to its Europe business. Sales from continuing operations of $645 million and adjusted operating earnings of $53 million were both lower than a year earlier but higher than the second quarter. The company also said it entered a put option agreement with Midas Atlantic Partners for a binding offer to acquire its Europe business, which it says would leave Sylvamo more focused on Latin America and North America.
Net sales from continuing operations were $645 million, versus $662 million in Q3 2025 and $614 million in Q2 2026.
Net loss was $199 million ($4.98 per diluted share), including a $284 million loss from discontinued operations.
Adjusted operating earnings were $53 million ($1.33 per diluted share), versus $72 million ($1.79) a year earlier.
Put option agreement with Midas Atlantic Partners for a binding offer to acquire the Europe business; dividend of $0.45 per share was paid Oct. 16.
Sylvamo entered a put option agreement with Midas Atlantic Partners, backed by The Najafi Companies, for a binding offer to acquire its Europe business. The buyer would take the business with an agreed level of working capital and cash, and Sylvamo would receive 20% of future distributions; no purchase price is stated. The company must complete works council and employee consultations before a final decision, and closing is expected by the end of the first quarter of 2027.
Buyer is Midas Atlantic Partners, in partnership with The Najafi Companies
Sylvamo would receive 20% of future distributions from the business in exchange for the transfer
Final decision follows consultations with works councils and employee representatives
Closing is expected by the end of the first quarter of 2027
Sylvamo reported a second-quarter 2026 net loss of $11 million, compared with net income of $15 million a year earlier, while net sales rose to $806 million from $794 million. Adjusted EBITDA fell to $60 million from $82 million, and free cash flow was negative $23 million, so shareholders face weaker profit in the quarter despite higher sales. Management said it expects a much better earnings performance in the second half of 2026.
Net loss of $11 million, or $0.28 per diluted share, versus net income of $15 million, or $0.37 per share, in Q2 2025
Net sales of $806 million, up from $794 million a year earlier and $755 million in Q1 2026
Adjusted EBITDA of $60 million versus $82 million in Q2 2025; free cash flow was negative $23 million
A $12 million valuation allowance on certain foreign deferred tax assets drove the effective tax rate to 1200%
Sylvamo reported a first-quarter 2026 net loss of $3 million, or $0.08 per diluted share, compared with net income of $27 million a year earlier. Net sales fell to $755 million from $821 million, and adjusted EBITDA dropped to $29 million from $90 million, which the company attributed to a transition year with capacity constraints, lower sales volume and higher costs. The company also declared a $0.45 dividend for the second quarter and did not provide new full-year guidance in the release.
Net loss of $3 million, or $0.08 per diluted share, versus net income of $27 million, or $0.65 per diluted share, in Q1 2025
Net sales of $755 million versus $821 million in Q1 2025 and $890 million in Q4 2025
Adjusted EBITDA of $29 million (4% margin) versus $90 million (11% margin) in Q1 2025; free cash flow was negative $59 million
Board declared a $0.45 dividend for the second quarter, paid April 28
Sylvamo reported fourth-quarter 2025 results, with net income of $33 million and diluted earnings per share of $0.83, down from $81 million and $1.94 in the same quarter of 2024. Net sales were $890 million, down from $970 million, and the company recorded an $11 million goodwill impairment in France, which reduced profit. Management said first-quarter 2026 results will be affected by lower volumes, higher energy costs and the absence of favorable one-time items, and did not give a numeric earnings outlook.
Q4 2025 net sales were $890 million versus $970 million in Q4 2024; diluted EPS was $0.83 versus $1.94.
Q4 2025 adjusted EBITDA was $125 million, a 14% margin, versus $157 million and 16% a year earlier.
Net special items were an after-tax charge of $11 million ($0.27 per diluted share), including the France goodwill impairment.
Full-year 2025 net income was $132 million versus $302 million in 2024, with free cash flow of $44 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Sylvamo filing is on SEC EDGAR ↗. 8-K briefs of other companies →